Review: Contaminants in Heparin: Review of the Literature, Molecular Profiling, and Clinical Implications

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical and applied thrombosis/hemostasis

• Publication date

  2011-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/1076029610392214PMID 21288929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin.

  2009cited by this paper
• Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.

  2009cited by this paper
• Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.

  2009cited by this paper
• Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.

  2009cited by this paper
• Improved impurity fingerprinting of heparin by high resolution (1)H NMR spectroscopy.

  2009cited by this paper
• Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.

  2009cited by this paper
• Orthogonal analytical approaches to detect potential contaminants in heparin

  2009influential reference
• Pattern-based recognition of heparin contaminants by an array of self-assembling fluorescent receptors.

  2009cited by this paper
• Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.

  2009cited by this paper
• Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.

  2009cited by this paper
• Screening of heparin API by near infrared reflectance and Raman spectroscopy.

  2009cited by this paper
• Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.

  2009cited by this paper
• Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.

  2009cited by this paper
• Increased Prevalence of Antiheparin Platelet Factor 4 Antibodies in Patients May Be Due to Contaminated Heparin

  2009influential reference
• Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.

  2008influential reference
• Contaminants in heparins continue to be unfolded.

  2008cited by this paper
• Contaminant in the Recalled Unfractionated Heparin Preparations: Where is the Problem?

  2008influential reference
• Contaminated heparin.

  2008cited by this paper
• Contaminated heparin associated with adverse clinical events and activation of the contact system.

  2008cited by this paper
• Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy.

  2008cited by this paper
• Outbreak of adverse reactions associated with contaminated heparin.

  2008influential reference
• Contaminated Heparin Preparations, Severe Adverse Events and the Contact System

  2008influential reference
• Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

  2008influential reference
• Heparin comes clean.

  2008cited by this paper
• Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.

  2008cited by this paper
• Detection of high-charge density polyanion contaminants in biomedical heparin preparations using potentiometric polyanion sensors.

  2008cited by this paper
• Biological Profile of the Hyper/Oversulfated Chondroitin Sulfate Contaminant Isolated from Recalled Heparin

  2008influential reference
• Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method.

  2008cited by this paper
• Anaphylatoxins: their role in bacterial infection and inflammation.

  2007cited by this paper
• Complement activation pathways: a bridge between innate and adaptive immune responses in asthma.

  2007cited by this paper
• An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization.

  2006cited by this paper
• New insights into the role of the complement pathway in allergy and asthma

  2005cited by this paper
• Heparin-Induced Thrombocytopenia

  2004cited by this paper
• Anaphylatoxins and infectious and non-infectious inflammatory diseases.

  2001cited by this paper
• Heparin-induced thrombocytopenia.

  1998influential reference
• Complement factors and their receptors.

  1997cited by this paper
• Multiple organ failure. Pathophysiology and potential future therapy.

  1992cited by this paper
• Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy.

  1989cited by this paper

• An integrated framework for modeling pharmaceutical supply chains with disruptions and risk mitigation

  2024cites this paper
• Analysis of Heparin Samples by Attenuated Total Reflectance Fourier-Transform Infrared Spectroscopy in the Solid State

  2023cites this paper
• Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for Binding

  2021cites this paper
• Recent developments in sensing of oversulfated chondroitin sulfate in heparin. A review

  2021cites this paper
• Chemical Modification of Glycosaminoglycan Polysaccharides

  2021cites this paper
• Spectrometric methods in pharmaceutical analysis of glycosaminoglycans: the state-of-the-art

  2020cites this paper
• Poly-Amido-Saccharides (PASs): Functional Synthetic Carbohydrate Polymers Inspired by Nature.

  2020cites this paper
• Galactosaminoglycans: Medical Applications and Drawbacks

  2019cites this paper
• Analysis of solid-state heparin samples by ATR-FTIR spectroscopy

  2019cites this paper
• Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary

  2019cites this paper
• Tools for the Quality Control of Pharmaceutical Heparin

  2019cites this paper
• Medical application of glycosaminoglycans: a review

  2018cites this paper
• Heparin Mimetics: Their Therapeutic Potential

  2017cites this paper
• Heparin inhibits the inflammation and proliferation of human rheumatoid arthritis fibroblast‑like synoviocytes through the NF‑κB pathway.

  2016cites this paper
• Establishment of chondroitin B lyase-based analytical methods for sensitive and quantitative detection of dermatan sulfate in heparin.

  2016cites this paper
• Alternative method for determination of contaminated heparin using chiral recognition.

  2014cites this paper
• Drugs that affect blood coagulation, fibrinolysis, and hemostasis

  2014cites this paper
• Sulfated polysaccharide extracted of the green algae Caulerpa racemosa increase the enzymatic activity and paw edema induced by sPLA2 from Crotalus durissus terrificus venom

  2013influential citation
• Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues.

  2013cites this paper
• Characterization of currently marketed heparin products: adverse event relevant bioassays.

  2012cites this paper
• New methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues

  2012cites this paper
• Recent Insights into the Molecular and Cellular Contributions to Venous Thrombosis

  2012cites this paper
• Fetal and neonatal effects of anticoagulants used in pregnancy: a review.

  2012cites this paper
• Article 9.indd

  2011cites this paper